Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 31, 2022 - Issue 2
Submit an article Journal homepage
284
Views
4
CrossRef citations to date
0
Altmetric
Review

Chemoresistance and resistance to targeted therapies in biliary tract cancer: what have we learned?

Christian Mayra Center for Physiology, Pathophysiology and Biophysics - Salzburg and Nuremberg, Institute for Physiology and Pathophysiology, Paracelsus Medical University, Salzburg, Austria;b Department of Internal Medicine I, Paracelsus Medical University/University Hospital Salzburg (Salk), Salzburg, AustriaView further author information
,
Tobias Kiesslicha Center for Physiology, Pathophysiology and Biophysics - Salzburg and Nuremberg, Institute for Physiology and Pathophysiology, Paracelsus Medical University, Salzburg, Austria;b Department of Internal Medicine I, Paracelsus Medical University/University Hospital Salzburg (Salk), Salzburg, AustriaView further author information
,
Dominik Paul Modestc Medical Department, Division of Hematology,Oncology, and Tumor Immunology (Campus Charité Mitte), Charité University Medicine Berlin, Berlin, GermanyView further author information
,
Sebastian Stintzingc Medical Department, Division of Hematology,Oncology, and Tumor Immunology (Campus Charité Mitte), Charité University Medicine Berlin, Berlin, GermanyView further author information
,
Matthias Ockerd Charité University Medicine Berlin, Berlin, Germany;e Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. Kg, Ingelheim, GermanyORCID Iconhttps://orcid.org/0000-0001-8263-6288View further author information
ORCID Icon &
Daniel Neureiterf Institute of Pathology, Paracelsus Medical University/University Hospital Salzburg (Salk), Salzburg, Austria;g Cancer ClusterSalzburg, AustriaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9155-5762View further author information
ORCID Icon
Pages 221-233 | Received 07 Dec 2021, Accepted 24 Jan 2022, Published online: 07 Feb 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Daniel Neureiter, Peter Ellinghaus & Matthias Ocker. (2023) FGFR inhibitor resistance in cholangiocarcinoma: current understanding and future directions. Expert Opinion on Pharmacotherapy 24:17, pages 1833-1837.
Read now
Pedro Luiz Serrano Uson Junior, Jeremiah Bearss, Hani M Babiker & Mitesh J Borad. (2023) Novel precision therapies for cholangiocarcinoma: an overview of clinical trials. Expert Opinion on Investigational Drugs 32:1, pages 69-75.
Read now

Articles from other publishers (2)

Linhua Yang, Hui Wang, Miaomiao Guo, Min He, Wei Zhang, Ming Zhan & Yingbin Liu. (2023) ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer. Cellular Oncology.
Crossref
Ju-Il Yang, Hye Lim Lee, Je-Jung Yun, Jungsoo Kim, Kyoung-Ha So, Young-IL Jeong & Dae-Hwan Kang. (2022) pH and Redox-Dual Sensitive Chitosan Nanoparticles Having Methyl Ester and Disulfide Linkages for Drug Targeting against Cholangiocarcinoma Cells. Materials 15:11, pages 3795.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.